Y7J-27634-42451
4 vaccinations
2 coded responses
50 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 300 / GA
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-05
Registered in v-safe
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-15
-
2021-04-22
Dose 2 — Pfizer-BioNTech
- 2021-04-22
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-06-03
- 2021-07-22
- 2021-10-21
-
2021-11-21
Dose 3 — Pfizer-BioNTech
- 2021-11-21
-
2021-11-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-11-23
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-12-05
- 2021-12-12
- 2021-12-19
- 2021-12-26
- 2022-01-02
- 2022-02-20
- 2022-05-22
-
2022-09-25
Dose 4 — Pfizer-BioNTech
- 2022-09-25
- 2022-09-26
-
2022-09-27
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2022-09-28
- 2022-09-29
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-09
-
2022-10-16
Survey response — day 21, dose 4MedDRA: Rhinorrhoea, Sputum discoloured, Upper-airway cough syndrome — Feeling: FairFree text: Runny nose and post nasal drip (yellow)MedDRA releases: 2024-11 · check-in free text available
-
2022-10-23
Survey response — day 28, dose 4MedDRA: Rhinorrhoea, Upper-airway cough syndrome — Feeling: GoodFree text: Runny nose, post nasal dripMedDRA releases: 2024-11 · check-in free text available
- 2022-10-30
- 2022-11-06
- 2022-12-25
- 2023-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech | |
| 3 | 2021-11-21 | Pfizer-BioNTech | No |
| 4 | 2022-09-25 | Pfizer-BioNTech | No |
Free text
Release 12 — day 21, dose 4
Symptoms: Runny nose and post nasal drip (yellow)
Release 12 — day 28, dose 4
Symptoms: Runny nose, post nasal drip
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sputum discoloured | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release